€68.80
0.29% day before yesterday
Xetra, Dec 06, 05:36 pm CET
ISIN
DE0005220909
Symbol
NXU
Index

NEXUS Stock price

€68.80
+0.30 0.44% 1M
+9.70 16.41% 6M
+10.60 18.21% YTD
+16.80 32.31% 1Y
+2.80 4.24% 3Y
+35.40 105.99% 5Y
+55.91 433.54% 10Y
Xetra, Closing price Fri, Dec 06 2024
+0.20 0.29%
ISIN
DE0005220909
Symbol
NXU
Index

Key metrics

Market capitalization €1.19b
Enterprise Value €1.19b
P/E (TTM) P/E ratio 44.36
EV/FCF (TTM) EV/FCF 56.68
EV/Sales (TTM) EV/Sales 4.57
P/S ratio (TTM) P/S ratio 4.55
P/B ratio (TTM) P/B ratio 4.47
Dividend yield 0.32%
Last dividend (FY23) €0.22
Revenue growth (TTM) Revenue growth 13.67%
Revenue (TTM) Revenue €261.00m
EBIT (operating result TTM) EBIT €37.18m
Free Cash Flow (TTM) Free Cash Flow €21.05m
Cash position €17.54m
EPS (TTM) EPS €1.55
P/E forward 40.57
P/S forward 4.41
EV/Sales forward 4.43
Show more

Is NEXUS a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.

NEXUS Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a NEXUS forecast:

6x Hold
100%

Analyst Opinions

6 Analysts have issued a NEXUS forecast:

Hold
100%

Financial data from NEXUS

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
261 261
14% 14%
100%
- Direct Costs 205 205
14% 14%
79%
56 56
14% 14%
21%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
56 56
16% 16%
22%
- Depreciation and Amortization 19 19
11% 11%
7%
EBIT (Operating Income) EBIT 37 37
19% 19%
14%
Net Profit 27 27
14% 14%
10%

In millions EUR.

Don't miss a Thing! We will send you all news about NEXUS directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

NEXUS Stock News

AD HOC NEWS
about one month ago
SCUR-Alpha 1766 GmbH (in future: Project Neptune Bidco GmbH) / DE0005220909
AD HOC NEWS
about one month ago
Der US-Finanzinvestor TA Associates will den auf Krankenhaus-Software spezialisierten deutschen Anbieter Nexus DE0005220909 kaufen.
AD HOC NEWS
about one month ago
SCUR-Alpha 1766 GmbH (in future: Project Neptune Bidco GmbH) / DE0005220909

Company Profile

NEXUS AG engages in the development and sale of software and hardware solutions. It operates its business through the Healthcare Software and Healthcare Services segments. The Healthcare Software segment provides software products on information systems for hospital and psychiatric, rehabilitation, and welfare institutions. The Healthcare Services offers information technology outsourcing services for institutions in the healthcare system. The company is headquartered in Donaueschingen, Germany.

Head office Germany
CEO Ingo Behrendt
Founded 1999
Website www.nexus-ag.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today